Panagopoulos I, Heim S
Cancer Genomics Proteomics. 2022; 19(6):647-672.
PMID: 36316036
PMC: 9620447.
DOI: 10.21873/cgp.20349.
Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S
Cancer Genomics Proteomics. 2022; 19(5):636-646.
PMID: 35985686
PMC: 9353729.
DOI: 10.21873/cgp.20348.
Panagopoulos I, Andersen K, Gorunova L, Eilert-Olsen M, Lund-Iversen M, Wessel-Aas T
Cancer Genomics Proteomics. 2022; 19(5):584-590.
PMID: 35985683
PMC: 9353724.
DOI: 10.21873/cgp.20343.
Elayyan J, Carmon I, Zecharyahu L, Batshon G, Maatuf Y, Reich E
Proc Natl Acad Sci U S A. 2022; 119(21):e2116855119.
PMID: 35594394
PMC: 9173807.
DOI: 10.1073/pnas.2116855119.
Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Heim S
Cancer Genomics Proteomics. 2022; 19(2):163-177.
PMID: 35181586
PMC: 8865047.
DOI: 10.21873/cgp.20312.
Rare and Novel Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia.
Panagopoulos I, Andersen K, Eilert-Olsen M, Rognlien A, Munthe-Kaas M, Micci F
Cancer Genomics Proteomics. 2021; 18(2):121-131.
PMID: 33608309
PMC: 7943214.
DOI: 10.21873/cgp.20247.
Whole‑exome sequencing identifies a novel mutation of SLC20A2 (c.C1849T) as a possible cause of hereditary multiple exostoses in a Chinese family.
Li Y, Lin X, Zhu M, Li J, Yuan Z, Xu H
Mol Med Rep. 2020; 22(3):2469-2477.
PMID: 32705272
PMC: 7411400.
DOI: 10.3892/mmr.2020.11298.
Fusion of the Gene With in a Hemangioma Carrying a t(X;15)(q22;q26) Chromosomal Translocation.
Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Lund-Iversen M, Micci F
Cancer Genomics Proteomics. 2020; 17(4):383-390.
PMID: 32576583
PMC: 7367601.
DOI: 10.21873/cgp.20197.
High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
Unachukwu U, Chada K, DArmiento J
Int J Mol Sci. 2020; 21(9).
PMID: 32365712
PMC: 7246488.
DOI: 10.3390/ijms21093151.
and Fusion Genes in Chondroid Syringoma.
Panagopoulos I, Gorunova L, Andersen K, Lund-Iversen M, Lobmaier I, Micci F
Cancer Genomics Proteomics. 2020; 17(3):237-248.
PMID: 32345665
PMC: 7259886.
DOI: 10.21873/cgp.20184.
and Fusion Genes in Osteoblastoma.
Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M
Cancer Genomics Proteomics. 2020; 17(2):161-168.
PMID: 32108038
PMC: 7078835.
DOI: 10.21873/cgp.20176.
Genetic Characterization of Myoid Hamartoma of the Breast.
Panagopoulos I, Gorunova L, Andersen H, Pedersen T, Lomo J, Lund-Iversen M
Cancer Genomics Proteomics. 2019; 16(6):563-568.
PMID: 31659109
PMC: 6885368.
DOI: 10.21873/cgp.20158.
Fusion of the and Genes in Epithelioid Osteoblastoma.
Panagopoulos I, Gorunova L, Lobmaier I, Lund-Iversen M, Andersen K, Holth A
Cancer Genomics Proteomics. 2019; 16(5):361-368.
PMID: 31467230
PMC: 6727071.
DOI: 10.21873/cgp.20141.
Mesenchymal tumors of the lung: diagnostic pathology, molecular pathogenesis, and identified biomarkers.
Hashimoto H, Tsugeno Y, Sugita K, Inamura K
J Thorac Dis. 2019; 11(Suppl 1):S9-S24.
PMID: 30775024
PMC: 6353741.
DOI: 10.21037/jtd.2018.12.04.
Cytogenetics of Spindle Cell/Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors.
Panagopoulos I, Gorunova L, Lund-Iversen M, Andersen K, Andersen H, Lobmaier I
Cancer Genomics Proteomics. 2018; 15(3):193-200.
PMID: 29695401
PMC: 5971011.
DOI: 10.21873/cgp.20077.
Extraskeletal osteochondroma within the iliopsoas muscle: case report.
Slavchev S, Georgiev G
SICOT J. 2017; 3:55.
PMID: 28905738
PMC: 5598206.
DOI: 10.1051/sicotj/2017043.
Genetic heterogeneity in leiomyomas of deep soft tissue.
Panagopoulos I, Gorunova L, Brunetti M, Agostini A, Andersen H, Lobmaier I
Oncotarget. 2017; 8(30):48769-48781.
PMID: 28591699
PMC: 5564723.
DOI: 10.18632/oncotarget.17953.
Differences in molecular regulation between osteochondroma and bizarre parosteal osteochondromatous proliferation.
Zhou X, Deng L, Han X, Chen Y, Wang J, Du S
Mol Med Rep. 2017; 16(1):801-805.
PMID: 28560436
PMC: 5482192.
DOI: 10.3892/mmr.2017.6634.
NFAT restricts osteochondroma formation from entheseal progenitors.
Ge X, Tsang K, He L, Garcia R, Ermann J, Mizoguchi F
JCI Insight. 2016; 1(4):e86254.
PMID: 27158674
PMC: 4855520.
DOI: 10.1172/jci.insight.86254.
The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Kaur H, Ali S, Huey L, Hutt-Cabezas M, Taylor I, Mao X
Cancer Lett. 2016; 377(1):55-64.
PMID: 27102002
PMC: 5091648.
DOI: 10.1016/j.canlet.2016.04.020.